Quantcast

Life Technologies Sources VigeneTech Image Analysis Engine for the Prodigy(TM) Microarray Platform

April 14, 2010

CARLISLE, Mass., April 14 /PRNewswire/ — VigeneTech Inc. has released an OEM image analysis solution to support Life Technologies Corporation’s Prodigy(TM), an automated, research-use array platform. Life Technologies is a global biotechnology tools company providing premier systems, consumables, and services for scientific researchers around the world. It sources VigeneTech, developers of novel image analysis, automation and instrumentation software, to provide the core image analysis engine for their state-of-the-art Prodigy microarray instrument.

The Prodigy System offers simplified automation, superior efficiency and reliability for research-use microarray applications and utilizes VigeneTech’s MicroVigene(TM) core image analysis technology for their end-to-end solution.

MicroVigene is a microarray image analysis software platform that delivers unparalleled performance and provides the highest level of speed, sensitivity, accuracy, and level of automation from a variety of challenging images commonly seen in the field. The flexible software can accommodate a variety of microarray applications and delivers the quality and performance necessary for Life Technologies’ current research applications and potential future clinical and diagnostic microarray applications.

“The Prodigy instrument is a complete, automated microarray solution. The image analysis solution we developed for Invitrogen/ Life Technologies leverages our core spot finding and quantitation technology and reaffirms VigeneTech as a leader in superior performing image analysis solutions,” Minzi Ruan, CEO of VigeneTech, commented. “We are excited to support the OEM relationship with Life Technologies.”

ABOUT VIGENETECH

VigeneTech is a leading provider of automated image and data analysis software solutions. VigeneTech offers novel scientific software and customized solutions for research applications, biomarker discovery, drug development, diagnostic and other clinical and pre-clinical applications. For more information about our offerings, visit http://www.vigenetech.com.


    Contact:

    Minzi Ruan Ph.D., CEO
    985 North Road
    Carlisle, Massachusetts, USA
    Tel: 978 371 5959
    Email: minzi@vigenetech.com

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE VigeneTech Inc.


Source: newswire



comments powered by Disqus